-
reportMedicines in Development for Cancer 2018 Report
America’s biopharmaceutical research companies are developing 1,100 medicines and vaccines for cancer.
73%
of survival gains
in cancer are attributable to new medicines
15.5
million +
Americans are cancer survivors as of January 2016
26%
the decline
in the cancer death rate since peaking in the 1990s
609,000+
U.S. cancer deaths
are expected in 2018
1.7
million +
estimated new cases of cancer in 2018 in the U.S.
